
A detailed guide to preclinical screening of antihypertensive agents for pharma professionals.
Vaibhavi M. | Feb 16, 2026

A deep dive into the clinical development, safety considerations, and commercial future of live biotherapeutic products.
Vaibhavi M. | Jan 27, 2026

Granulation bottlenecks rarely cause failures, but they quietly reduce throughput, inflate costs, and erode margins in pharma manufacturing.
Mrudula Kulkarni | Jan 21, 2026

Next-gen CAR-T cells are designed to overcome the tumor microenvironment and finally make solid tumor immunotherapy possible.
Mrudula Kulkarni | Dec 22, 2025

Non-viral delivery systems enable safer, scalable gene therapy and mRNA delivery, reshaping advanced therapeutics beyond viral vectors.
Mrudula Kulkarni | Dec 19, 2025